CCTG OV.25, STICS and STONES
Trial Description:
A randomized phase II double-blind placebo-controlled trial of Acetylsalicylic acid (ASA) in chemoprevention of ovarian cancer in women with BRCA1/2 mutations
Lead Cooperative Group:
Participating Groups:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Recruiting
Contact person:
aoza